Cynosure Group LLC Lowers Stake in Mettler-Toledo International Inc. (NYSE:MTD)

Cynosure Group LLC reduced its holdings in shares of Mettler-Toledo International Inc. (NYSE:MTDFree Report) by 92.7% during the 1st quarter, according to its most recent 13F filing with the SEC. The fund owned 236 shares of the medical instruments supplier’s stock after selling 2,987 shares during the period. Cynosure Group LLC’s holdings in Mettler-Toledo International were worth $314,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors also recently bought and sold shares of MTD. B. Riley Wealth Advisors Inc. boosted its holdings in shares of Mettler-Toledo International by 46.0% in the third quarter. B. Riley Wealth Advisors Inc. now owns 238 shares of the medical instruments supplier’s stock valued at $264,000 after acquiring an additional 75 shares in the last quarter. CVA Family Office LLC purchased a new stake in shares of Mettler-Toledo International in the fourth quarter valued at about $27,000. Raymond James Financial Services Advisors Inc. boosted its holdings in shares of Mettler-Toledo International by 25.4% in the fourth quarter. Raymond James Financial Services Advisors Inc. now owns 1,676 shares of the medical instruments supplier’s stock valued at $2,033,000 after acquiring an additional 340 shares in the last quarter. Assenagon Asset Management S.A. boosted its holdings in shares of Mettler-Toledo International by 73.1% in the fourth quarter. Assenagon Asset Management S.A. now owns 69,544 shares of the medical instruments supplier’s stock valued at $84,354,000 after acquiring an additional 29,361 shares in the last quarter. Finally, Values First Advisors Inc. boosted its holdings in shares of Mettler-Toledo International by 2.6% in the fourth quarter. Values First Advisors Inc. now owns 1,139 shares of the medical instruments supplier’s stock valued at $1,382,000 after acquiring an additional 29 shares in the last quarter. 95.07% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several analysts have recently weighed in on MTD shares. Stifel Nicolaus lifted their target price on shares of Mettler-Toledo International from $1,270.00 to $1,510.00 and gave the company a “buy” rating in a report on Monday, May 13th. Jefferies Financial Group reaffirmed an “underperform” rating and issued a $1,250.00 target price (up previously from $1,230.00) on shares of Mettler-Toledo International in a report on Monday, June 3rd. StockNews.com raised shares of Mettler-Toledo International from a “hold” rating to a “buy” rating in a report on Thursday, July 11th. Robert W. Baird boosted their price objective on shares of Mettler-Toledo International from $1,212.00 to $1,360.00 and gave the stock a “neutral” rating in a report on Monday, May 13th. Finally, The Goldman Sachs Group boosted their price objective on shares of Mettler-Toledo International from $1,150.00 to $1,300.00 and gave the stock a “neutral” rating in a report on Tuesday, July 9th. Two analysts have rated the stock with a sell rating, four have given a hold rating and three have given a buy rating to the company. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $1,301.25.

Check Out Our Latest Stock Report on MTD

Mettler-Toledo International Stock Up 0.8 %

Shares of NYSE:MTD traded up $11.30 during trading on Tuesday, reaching $1,383.92. The stock had a trading volume of 28,429 shares, compared to its average volume of 143,405. The business has a fifty day moving average price of $1,424.67 and a 200-day moving average price of $1,311.19. The stock has a market cap of $29.56 billion, a P/E ratio of 38.46, a PEG ratio of 3.61 and a beta of 1.17. Mettler-Toledo International Inc. has a fifty-two week low of $928.49 and a fifty-two week high of $1,535.86.

Mettler-Toledo International (NYSE:MTDGet Free Report) last issued its quarterly earnings results on Thursday, May 9th. The medical instruments supplier reported $8.89 EPS for the quarter, topping the consensus estimate of $7.61 by $1.28. Mettler-Toledo International had a net margin of 20.55% and a negative return on equity of 662.32%. The firm had revenue of $925.95 million during the quarter, compared to analyst estimates of $879.72 million. During the same quarter in the prior year, the business posted $8.69 earnings per share. Mettler-Toledo International’s revenue for the quarter was down .3% compared to the same quarter last year. As a group, equities analysts forecast that Mettler-Toledo International Inc. will post 40.13 EPS for the current year.

Insider Buying and Selling

In other Mettler-Toledo International news, Director Thomas P. Salice sold 1,268 shares of the business’s stock in a transaction that occurred on Monday, May 13th. The shares were sold at an average price of $1,490.18, for a total transaction of $1,889,548.24. Following the completion of the sale, the director now directly owns 244 shares in the company, valued at $363,603.92. The transaction was disclosed in a legal filing with the SEC, which is available through this link. In other Mettler-Toledo International news, Director Thomas P. Salice sold 1,268 shares of the business’s stock in a transaction that occurred on Monday, May 13th. The shares were sold at an average price of $1,490.18, for a total transaction of $1,889,548.24. Following the completion of the sale, the director now directly owns 244 shares in the company, valued at $363,603.92. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CFO Shawn Vadala sold 300 shares of the business’s stock in a transaction that occurred on Monday, May 13th. The stock was sold at an average price of $1,457.07, for a total transaction of $437,121.00. Following the sale, the chief financial officer now owns 4,914 shares of the company’s stock, valued at $7,160,041.98. The disclosure for this sale can be found here. Over the last quarter, insiders sold 3,278 shares of company stock valued at $4,871,849. Insiders own 1.94% of the company’s stock.

Mettler-Toledo International Profile

(Free Report)

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.Its industrial instruments comprise industrial weighing instruments and related terminals, automatic dimensional measurement and data capture solutions, vehicle scale systems, industrial software, metal detection equipment, x-ray systems, check weighing equipment, camera-based imaging equipment, track-and-trace solutions, and product inspection systems.

Further Reading

Institutional Ownership by Quarter for Mettler-Toledo International (NYSE:MTD)

Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.